The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Diltiazem is a nondihydropyridine (non-DHP) calcium channel blocker used in the treatment of hypertension, angina pectoris, and some types of arrhythmia. It relaxes the smooth muscles in the walls of arteries, which opens (dilates) the arteries, allows blood to flow more easily, and lowers blood pressure. Additionally, it lowers blood pressure by acting on the heart itself to reduce the rate, strength, and conduction speed of each beat.
The global Diltiazem market was valued at US$ 336 million in 2023 and is anticipated to reach US$ 505 million by 2030, witnessing a CAGR of 6.1% during the forecast period 2024-2030.
North American market for Diltiazem is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Diltiazem is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Diltiazem include Bausch Health, Teva, Mylan, Athenex, Pfizer, Akorn, Sandoz, Sun Pharma and Hikma Pharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Diltiazem, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diltiazem.
Report Scope
The Diltiazem market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Diltiazem market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Diltiazem manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bausch Health
Teva
Mylan
Athenex
Pfizer
Akorn
Sandoz
Sun Pharma
Hikma Pharmaceuticals
Zydus Pharmaceuticals
Par Pharmaceutical
Segment by Type
Tablet
Capsule
Injection
Segment by Application
Angina
Hypertension
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Diltiazem manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Diltiazem in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Diltiazem is a nondihydropyridine (non-DHP) calcium channel blocker used in the treatment of hypertension, angina pectoris, and some types of arrhythmia. It relaxes the smooth muscles in the walls of arteries, which opens (dilates) the arteries, allows blood to flow more easily, and lowers blood pressure. Additionally, it lowers blood pressure by acting on the heart itself to reduce the rate, strength, and conduction speed of each beat.
The global Diltiazem market was valued at US$ 336 million in 2023 and is anticipated to reach US$ 505 million by 2030, witnessing a CAGR of 6.1% during the forecast period 2024-2030.
North American market for Diltiazem is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Diltiazem is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Diltiazem include Bausch Health, Teva, Mylan, Athenex, Pfizer, Akorn, Sandoz, Sun Pharma and Hikma Pharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Diltiazem, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diltiazem.
Report Scope
The Diltiazem market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Diltiazem market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Diltiazem manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bausch Health
Teva
Mylan
Athenex
Pfizer
Akorn
Sandoz
Sun Pharma
Hikma Pharmaceuticals
Zydus Pharmaceuticals
Par Pharmaceutical
Segment by Type
Tablet
Capsule
Injection
Segment by Application
Angina
Hypertension
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Diltiazem manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Diltiazem in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Diltiazem Market Overview
1.1 Product Overview and Scope of Diltiazem
1.2 Diltiazem Segment by Type
1.2.1 Global Diltiazem Market Value Comparison by Type (2024-2030)
1.2.2 Tablet
1.2.3 Capsule
1.2.4 Injection
1.3 Diltiazem Segment by Application
1.3.1 Global Diltiazem Market Value by Application: (2024-2030)
1.3.2 Angina
1.3.3 Hypertension
1.4 Global Diltiazem Market Size Estimates and Forecasts
1.4.1 Global Diltiazem Revenue 2019-2030
1.4.2 Global Diltiazem Sales 2019-2030
1.4.3 Global Diltiazem Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Diltiazem Market Competition by Manufacturers
2.1 Global Diltiazem Sales Market Share by Manufacturers (2019-2024)
2.2 Global Diltiazem Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Diltiazem Average Price by Manufacturers (2019-2024)
2.4 Global Diltiazem Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Diltiazem, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Diltiazem, Product Type & Application
2.7 Diltiazem Market Competitive Situation and Trends
2.7.1 Diltiazem Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Diltiazem Players Market Share by Revenue
2.7.3 Global Diltiazem Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Diltiazem Retrospective Market Scenario by Region
3.1 Global Diltiazem Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Diltiazem Global Diltiazem Sales by Region: 2019-2030
3.2.1 Global Diltiazem Sales by Region: 2019-2024
3.2.2 Global Diltiazem Sales by Region: 2025-2030
3.3 Global Diltiazem Global Diltiazem Revenue by Region: 2019-2030
3.3.1 Global Diltiazem Revenue by Region: 2019-2024
3.3.2 Global Diltiazem Revenue by Region: 2025-2030
3.4 North America Diltiazem Market Facts & Figures by Country
3.4.1 North America Diltiazem Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Diltiazem Sales by Country (2019-2030)
3.4.3 North America Diltiazem Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Diltiazem Market Facts & Figures by Country
3.5.1 Europe Diltiazem Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Diltiazem Sales by Country (2019-2030)
3.5.3 Europe Diltiazem Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Diltiazem Market Facts & Figures by Country
3.6.1 Asia Pacific Diltiazem Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Diltiazem Sales by Country (2019-2030)
3.6.3 Asia Pacific Diltiazem Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Diltiazem Market Facts & Figures by Country
3.7.1 Latin America Diltiazem Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Diltiazem Sales by Country (2019-2030)
3.7.3 Latin America Diltiazem Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Diltiazem Market Facts & Figures by Country
3.8.1 Middle East and Africa Diltiazem Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Diltiazem Sales by Country (2019-2030)
3.8.3 Middle East and Africa Diltiazem Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Diltiazem Sales by Type (2019-2030)
4.1.1 Global Diltiazem Sales by Type (2019-2024)
4.1.2 Global Diltiazem Sales by Type (2025-2030)
4.1.3 Global Diltiazem Sales Market Share by Type (2019-2030)
4.2 Global Diltiazem Revenue by Type (2019-2030)
4.2.1 Global Diltiazem Revenue by Type (2019-2024)
4.2.2 Global Diltiazem Revenue by Type (2025-2030)
4.2.3 Global Diltiazem Revenue Market Share by Type (2019-2030)
4.3 Global Diltiazem Price by Type (2019-2030)
5 Segment by Application
5.1 Global Diltiazem Sales by Application (2019-2030)
5.1.1 Global Diltiazem Sales by Application (2019-2024)
5.1.2 Global Diltiazem Sales by Application (2025-2030)
5.1.3 Global Diltiazem Sales Market Share by Application (2019-2030)
5.2 Global Diltiazem Revenue by Application (2019-2030)
5.2.1 Global Diltiazem Revenue by Application (2019-2024)
5.2.2 Global Diltiazem Revenue by Application (2025-2030)
5.2.3 Global Diltiazem Revenue Market Share by Application (2019-2030)
5.3 Global Diltiazem Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Bausch Health
6.1.1 Bausch Health Corporation Information
6.1.2 Bausch Health Description and Business Overview
6.1.3 Bausch Health Diltiazem Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Bausch Health Diltiazem Product Portfolio
6.1.5 Bausch Health Recent Developments/Updates
6.2 Teva
6.2.1 Teva Corporation Information
6.2.2 Teva Description and Business Overview
6.2.3 Teva Diltiazem Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Teva Diltiazem Product Portfolio
6.2.5 Teva Recent Developments/Updates
6.3 Mylan
6.3.1 Mylan Corporation Information
6.3.2 Mylan Description and Business Overview
6.3.3 Mylan Diltiazem Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Mylan Diltiazem Product Portfolio
6.3.5 Mylan Recent Developments/Updates
6.4 Athenex
6.4.1 Athenex Corporation Information
6.4.2 Athenex Description and Business Overview
6.4.3 Athenex Diltiazem Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Athenex Diltiazem Product Portfolio
6.4.5 Athenex Recent Developments/Updates
6.5 Pfizer
6.5.1 Pfizer Corporation Information
6.5.2 Pfizer Description and Business Overview
6.5.3 Pfizer Diltiazem Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Pfizer Diltiazem Product Portfolio
6.5.5 Pfizer Recent Developments/Updates
6.6 Akorn
6.6.1 Akorn Corporation Information
6.6.2 Akorn Description and Business Overview
6.6.3 Akorn Diltiazem Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Akorn Diltiazem Product Portfolio
6.6.5 Akorn Recent Developments/Updates
6.7 Sandoz
6.6.1 Sandoz Corporation Information
6.6.2 Sandoz Description and Business Overview
6.6.3 Sandoz Diltiazem Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sandoz Diltiazem Product Portfolio
6.7.5 Sandoz Recent Developments/Updates
6.8 Sun Pharma
6.8.1 Sun Pharma Corporation Information
6.8.2 Sun Pharma Description and Business Overview
6.8.3 Sun Pharma Diltiazem Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Sun Pharma Diltiazem Product Portfolio
6.8.5 Sun Pharma Recent Developments/Updates
6.9 Hikma Pharmaceuticals
6.9.1 Hikma Pharmaceuticals Corporation Information
6.9.2 Hikma Pharmaceuticals Description and Business Overview
6.9.3 Hikma Pharmaceuticals Diltiazem Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Hikma Pharmaceuticals Diltiazem Product Portfolio
6.9.5 Hikma Pharmaceuticals Recent Developments/Updates
6.10 Zydus Pharmaceuticals
6.10.1 Zydus Pharmaceuticals Corporation Information
6.10.2 Zydus Pharmaceuticals Description and Business Overview
6.10.3 Zydus Pharmaceuticals Diltiazem Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Zydus Pharmaceuticals Diltiazem Product Portfolio
6.10.5 Zydus Pharmaceuticals Recent Developments/Updates
6.11 Par Pharmaceutical
6.11.1 Par Pharmaceutical Corporation Information
6.11.2 Par Pharmaceutical Diltiazem Description and Business Overview
6.11.3 Par Pharmaceutical Diltiazem Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Par Pharmaceutical Diltiazem Product Portfolio
6.11.5 Par Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Diltiazem Industry Chain Analysis
7.2 Diltiazem Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Diltiazem Production Mode & Process
7.4 Diltiazem Sales and Marketing
7.4.1 Diltiazem Sales Channels
7.4.2 Diltiazem Distributors
7.5 Diltiazem Customers
8 Diltiazem Market Dynamics
8.1 Diltiazem Industry Trends
8.2 Diltiazem Market Drivers
8.3 Diltiazem Market Challenges
8.4 Diltiazem Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
